In Focus

Here you find information and background details about topics that are in the focus of Bayer Schering Pharma AG.

Current topic


Bayers Perspective on Innovation 2008
12th December 2008 - New technologies and products at the Perspective on Innovation 2008
At this year´s press conference on "Bayer´s Perspective on Innovation 2008", innovation champions of the Bayer group were in the focus. Werner Wenning (Chairman of the Board of Management of Bayer AG) and Dr. Wolfgang Plischke (member of the Board of Management of Bayer AG, responsible for innovation, technology and environment) presented the work in research and development at Bayer HealthCare, Bayer Crop Science and Bayer Material Science. more



Further information and background details


Newly adopted pharmaceutical package recognises importance of pharmaceutical industry – need to ensure patient safety is key
On Dec 10, 2008 The European Commission published a package of proposals on pharmaceutical regulation.
EFPIA, the voice of the research-based pharmaceutical industry in Europe welcomes the release of the long-awaited European Commission’s ‘Pharmaceutical package’. However EFPIA urges the institutions not lose focus on the core issue of patient safety. more


28/11/2008
EFPIA Press Meeting – Press Statement on the sector inquiry into pharmaceuticals
Arthur J. Higgins, EFPIA President and CEO of Bayer HealthCare, takes the opportunity to comment on the sector inquiry into competition in the pharmaceuticals sector. The preliminary report on the inquiry was published November 28, 2008. more


15/10/2008
7th International Dialogue on Population and Sustainable Development
“Women are often not allowed to do what they want” – 7th International Dialogue looked at opportunities and deficits in gender equality and sexual self-determination.

The 7th International Dialogue on Population and Sustainable Development in Berlin started with a high-profile panel discussion on October 15, 2008. more


26/09/2008
World Contraception Day 2008
World Contraception Day is a worldwide multinational initiative that was first held on September 26 in 2007. more


06/20/2008
Research-based pharmaceutical industry in Europe to celebrate 30. anniversary at Annual Meetings
Review of success and first results of EFPIA’s AIMS roadmap
In his address on the occasion of EFPIA’s 30th anniversary, EFPIA President and CEO of Bayer Healthcare Arthur Higgins showcased some of the historic milestones amongst the numerous achievements in the history of the Federation since 1978 – the year artificial insulin was discovered. more


06/20/2008
Research-based pharmaceutical industry in Europe celebrated 30. anniversary at Annual Meetings
EFPIA President Higgins highlighted pharmaceutical industry’s contribution to health and wealth of EU citizens more


02/28/2008
The "Science Tunnel" – a Journey Through the World of Modern Science
Multimedia exhibition by the Max Planck Society was in Berlin from Feb. 26 – April 13, 2008. more


02/27/2008
Greater patient empowerment at the basis of a modern healthcare system
Arthur Higgins, Chairman of the Board of Management of Bayer Schering Pharma AG, spoke at the Economist Conference in London on February 27, 2008. more


02/27/2008
Contributing to Global Health: IFPMA Focus Paper Spells Out position of R&D-Based Pharmaceutical Industry
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has published a paper pointing out focus and actions of the pharmaceutical industry as regards the fight against the disproportionate disease burden. more


02/01/2008
A strong partnership: Bayer Schering Pharma AG New Member of Reproductive Health Supplies Coalition (RHSC)
Bayer Schering Pharma AG extend their network with respect to the Family Planning Program. The Reproductive Health Supplies Coalition (RHSC) has admitted the company as a new member. more


11/19/2007
EU Conference on Pharmaceutical Innovation - Press Statement
Press Statement Arthur Higgins, Chairman of the Board of Management of Bayer Schering Pharma AG, November 19, 2007. more


11/19/2007
EU Conference on Pharmaceutical Innovation - Keynote Address
Keynote Address Arthur Higgins, Chairman of the Board of Management of Bayer Schering Pharma AG, of November 19, 2007. more


10/29/2007
From molecules to medicine
"From Molecules to Drugs" – BSP Scientists Invite the Public to See how they Work 2,000 visitors tour the laboratories at Bayer Schering Pharma. more


10/09/2007
Early detection of the disease even in the cells
Kick-off event for the Molecular Imaging Innovation Alliance at Bayer Schering Pharma. more


10/09/2007
Population and Sustainable Development – 6th International Dialog discusses the organization of urban growth and family planning
Berlin – Reasonable planning of urban growth and family planning are the topics of the 6th International Dialog on Population and Sustainable Development which began on Monday in Berlin. more


10/09/2007
Using urbanization – 6th International Dialogue on Population and Sustainable Development
6th International Dialogue on Population and Sustainable Development sees progressive urbanization as an opportunity to overcome poverty more


09/24/2007
World Contraception Day 2007
World Contraception Day is a multinational campaign aiming to raise the awareness of contraception among women and to improve the level of education regarding reproductive and sexual health. more


08/21/2007
Social Commitment for Berlin
As a globally successful pharmaceuticals company, Bayer Schering Pharma – headquartered in Berlin – feels closely connected to the German federal capital. more


07/20/2007
PT Bayer Indonesia ranked as Indonesia's most admired pharmaceutical company
The Indonesian subsidiary of Bayer AG, PT Bayer Indonesia, received no. 1 ranking as “Indonesia’s Most Admired Company” (IMAC) in the pharmaceutical category for the year 2007. more

Search
Font size
- 1 2 3 + Font size

click to adjust

Page tools
Your opinion counts
Podcast Center

http://www.bonefos.com/scripts/pages/en/press/focus_on/index.php

Copyright © Bayer Schering Pharma AG